Home / Conditions / Type 2 Diabetes (page 49)

Type 2 Diabetes

Type 2 Diabetes Research and News: Type 2 diabetes is a metabolic disorder. Though most commonly diagnosed in the elderly, younger adults and even children are increasingly subject to the disease. 9.4% of the US population has Type 2 diabetes or about 30 million Americans. Approximately 95% of all adults diagnosed with diabetes have Type 2. New tools, techniques and treatments can help you improve outcomes for your Type 2 diabetes patients.

Hormone Therapy: Does it Lead to Increased Incidence of Diabetes in Trans Men and Women?

Studies have found that there may be a connection between hormone therapy use and type 2 diabetes, putting transgender individuals at an increased risk.   Transgender individuals commonly use hormone therapy to generate the person’s desired physical characteristics. In addition to transforming the individuals’ physical characteristics, hormone therapy can also alter …

Read More »

Blaming the COVID-19 Pandemic for Weight Gain

The current COVID-19 Pandemic may be to blame for weight gain in patients at a higher risk of developing diabetes. The Healthier You: NHS Diabetes Prevention Program (NHS DPP) developed by the National Health Service (NHS) in 2016 was created to delay or avert the emergence of type 2 diabetes …

Read More »

Postpartum Use of Metformin to Prevent Type 2 Diabetes Mellitus

Metformin is used as first-line therapy but can also be used prophylactically. Almost three-quarters of women who experience gestational diabetes mellitus (GDM) will eventually develop type 2 diabetes (T2DM) in their lifetime. According to Whelan et al., “GDM is one of the most common complications of pregnancy affecting 6-8% of …

Read More »

Dialysis and Anti-diabetic Drugs

The association between anti-diabetic drug use and survival outcomes in patients on dialysis. Diabetic kidney disease that leads to end-stage renal disease (ESRD) and dialysis is common among patients with type 2 diabetes. However, the impact of anti-diabetic drugs on patients undergoing dialysis is rarely studied. Most patients with ESRD …

Read More »

Finerenone improves cardiovascular outcomes in patients with Type 2 Diabetes and CKD

Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, improves cardiovascular events (MI, stroke, HF) in Type 2 Diabetes and Chronic Kidney Disease (CKD) patients.  Some risk factors for cardiovascular diseases (CVD), such as high blood glucose, blood pressure, serum cholesterol, and BMI, are also associated with CKD and type 2 diabetes. …

Read More »

The Role of Pharmacists in Diabetes Education

Pharmacists in the community setting play a role in diabetes screening and management by providing direct patient care. With the constant increase in the prevalence of diabetes, education is vital in understanding how to control disease progression. Pharmacists play an essential role in disease management, assessing medication adherence, and educating …

Read More »